Bumetanide Injection
Product Images NDC 51662-1449

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 51662-1449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

Bumetanide Injection, USP is a potent diuretic that requires careful medical supervision to avoid excessive diuresis and electrolyte depletion. Proper dosage and administration must be determined for each patient. Refer to DOSAGE AND ADMINISTRATION for guidelines.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

This is a description of a medication called Bumetanide in injectable form. The medication is intended for intravenous or intramuscular use and is contained in a single-dose vial of 4mL. Each milliliter of the medication contains 1mg of the active ingredient. The vial contains benzyl alcohol as a preservative. The first line appears to be a product code or identifier that might be useful for tracking or inventory purposes.*

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label (Vial Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.